Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Real-World Experience from a Single Spanish Regional Hospital
E Rodilla, MI Orts-Martinez, MA Sanz-Caballer… - 2021 - preprints.org
The aim is to evaluate a program for direct oral anticoagulants (DOACs) management in
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …
nonvalvular atrial fibrillation (NVAF) patients, according to patient profiles, appropriateness …
Patterns and outcomes of switching direct oral anticoagulants in non-valvular atrial fibrillation: A real-world experience from Spain
E Rodilla, MI Orts-Martínez, MA Sanz-Caballer… - Revista Clínica …, 2023 - Elsevier
Aims The aim is to evaluate a management program for direct oral anticoagulants (DOACs)
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
in non-valvular atrial fibrillation (NVAF) patients according to their profiles, appropriateness …
Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish …
M Cerda, JJ Cerezo-Manchado… - Journal of …, 2018 - becarispublishing.com
Aim: To analyze the effectiveness and safety of direct oral anticoagulants (DOACs) in atrial
fibrillation (AF) patients attended in clinical practice. Methods: Observational and …
fibrillation (AF) patients attended in clinical practice. Methods: Observational and …
Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry
B Navarro-Almenzar, JJ Cerezo-Manchado… - Current Medical …, 2019 - Taylor & Francis
Aim: To analyse the effectiveness and safety of DOAC (direct oral anticoagulants) in non-
valvular atrial fibrillation (NVAF) patients attending clinical practice. Methods: Retrospective …
valvular atrial fibrillation (NVAF) patients attending clinical practice. Methods: Retrospective …
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
NW Andersson, H Svanström, M Lund… - International Journal of …, 2018 - Elsevier
Background The comparative effectiveness and safety of individual direct oral
anticoagulants (DOACs) in clinical practice is largely unknown. The study objectives were to …
anticoagulants (DOACs) in clinical practice is largely unknown. The study objectives were to …
Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis
M Durand, ME Schnitzer, M Pang… - British Journal of …, 2021 - Wiley Online Library
Aims There are conflicting signals in the literature about comparative safety and
effectiveness of direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF) …
effectiveness of direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF) …
Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
A Briasoulis, Y Gao, C Inampudi, P Alvarez… - BMC cardiovascular …, 2020 - Springer
Background We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF)
taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and …
taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and …
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense …
Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at
least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among …
least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among …
[HTML][HTML] Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation
K Lavoie, MH Turgeon, C Brais… - Journal of Atrial …, 2016 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) is a common cardiovascular disease for which newer oral
anticoagulants are available. The main objective of this study was to evaluate the …
anticoagulants are available. The main objective of this study was to evaluate the …
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs)
G Nemola, A Russi, G Cozzani, G Leo… - The American Journal of …, 2023 - Elsevier
Direct oral anticoagulants (DOACs) represent the cornerstone therapy for cardioembolic
events prevention in patients with nonvalvular atrial fibrillation (NVAF). In practice, the …
events prevention in patients with nonvalvular atrial fibrillation (NVAF). In practice, the …